INS and type 2 diabetes mellitus: GCGR mutations may be related to hyperglucagonemia via the impairment of endogenous glucagon autofeedback, to high hepatic glucose output in T2D via elevated glycogenolysis and/or gluconeogenesis, and to abnormal insulin secretion via the glucagon resistance of β cells in T2D.